Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market - Sangamo Therapeutics (NASD
Summary
RICHMOND, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that its common stock...
Description
RICHMOND, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that its common stock...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source